ReveraGen Biopharma, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 30
Rang # Quantité totale PI 47 776
Note d'activité PI 2,2/5.0    24
Rang # Activité PI 33 423
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

20 2
2 0
6 0
0
 
Dernier brevet 2024 - Non-hormonal steroid modulators ...
Premier brevet 2009 - Non-hormonal steroid modulators ...
Dernière marque 2014 - REVERAGEN BIOPHARMA
Première marque 2014 - REVERAGEN BIOPHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Treatment of nf-kb-mediated disease. The present disclosure provides methods of treating or redu...
Invention Treatment of congenital adrenal hypoplasia. The present disclosure provides a method of treating...
2023 Invention Non-hormonal steroid modulators of nf-kappa beta for treatment of disease. The present invention...
Invention Non-hormonal steroid modulators of nf-kb for treatment of disease. The present invention relates...
2022 Invention Treatment of nf-κb-mediated disease. The present disclosure provides methods of treating or reduc...
Invention Treatment of congenital adrenal hypoplasia. The present disclosure provides a method of treating ...
Invention Aqueous oral pharmaceutical suspension compositions. Provided is an aqueous oral pharmaceutical s...
Invention Crystalline forms of vamorolone. Provided are certain polymorphic forms of vamorolone as well as...
2021 Invention Vamorolone for the treatment of muscular dystrophy. The present disclosure provides methods of tr...
2020 Invention Non-hormonal steroid modulators of nf-kb for treatment of disease. The present invention relates ...
Invention Non-hormonal steroid modulators of nf-κβ for treatment of disease. The present invention relates ...
2018 Invention Non-hormonal steroid modulators of nf-kb for treatment of disease. Provided herein is a pharmaceu...
2016 Invention Non-hormonal steroid modulators of nf-κb for treatment of disease. The present invention relates ...
Invention Non-hormonal steroid modulators of nf-kappa beta for treatment of disease. The present invention ...
2014 P/S Pharmaceutical research and development
Invention Methods and agents to increase therapeutic dystrophin expression in muscle. Agents and methods fo...
2012 Invention Non-hormonal steroid modulators of nf-kb for treatment of disease.
2011 Invention Non-hormonal steroid modulators of nf-κb for treatment of disease. The present invention relate...
2009 Invention Non-hormonal steroid modulators of nf-.kappa.b for treatment of disease. The present invention re...